Skip to main content

Advertisement

SpringerLink
Log in

Natural Haemophilus influenzae type b capsular polysaccharide antibodies in 412 infants and children from West Africa (Burkina-Faso) and France: A cross-sectional serosurvey

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Prior to possible introduction of large-scale vaccination programmes, an estimation and comparison of naturally acquired immunity against Haemophilus influenzae type b (Hib) was carried out in two populations of age-stratified infants and children (from birth to 14 years old) in Burkina-Faso (West Africa) (n = 206) and France (n = 206). Hib capsular polysaccharide antibodies were detected by an ELISA method. The difference in the percentages of minimum protective levels for the two populations were not significant (0.15 μg/ml) for newborns (0–1 month) but became significant as early as 2 to 3 months of age (p < 0.01) when lower levels were found among infants from Burkina-Faso. Subsequently, the percentages in both countries remained low until 11 months of age and showed no significant differences. For children between 12 and 35 months, the results ≥ 0.15 μg/ml were significantly higher in France (p ≤ 0.05). From 36 months, the percentage of minimum seropositivity increased in Burkina-Faso, so that the difference was no longer significant. In each country, the percentage of children with the minimum protective level varied significantly (p les; 0.05) according to age (0–47 months). None of the children from Burkina-Faso or France had antibody levels > 1.0 μg/ml before one year of age. Thereafter, only 9.51% of French children in the 12- to 17-month age stratum and 19.2% over 4 years of age had antibody levels > 1.0 μg/ml. There were no non-detectable results for children over 4 years of age, and the means for natural detectable Hib CP antibodies were > 0.15 μg/ml for both populations. Hib invasive infections depend on climate, socioeconomic status and ethnic and genetic factors. In Burkina-Faso, the large number of infants and children under 4 years of age susceptible to Hib infections suggests that large scale vaccination programmes are needed soon after birth. However, it would first be necessary to evaluate such factors as the frequency of Hib diseases in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sansoni A, Rappuoli R, Viti S, Costantino P, Fanti O, Cellesi C. Immunity to Haemophilus influenzae type b on sample population from central Italy. Vaccine 1992; 10: 627–630.

    Google Scholar 

  2. Jordens JZ, Slack MPE. Haemophilus influenzae: Then and now. Eur J Clin Microbiol Infect Dis 1995; 14: 935–948.

    Google Scholar 

  3. Robbins JB, Schneerson R, Anderson P, Smith DH. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines. JAMA 1996; 276: 1181–1185.

    Google Scholar 

  4. Catania S, Ronchetti MP, Catania N, Berardelli G, D'Aviera L, Rossi F, et al. Haemophilus influenzae type b meningitis: Pediatric overview. Riv Eur Sci Med Farmacol 1996; 18: 163–167.

    Google Scholar 

  5. Van Alphen L, Spanjaard L, van der Ende A, Schuurman I, Dankert J. Effect of nationwide vaccination of 3–month-old infants in the Netherlands with conjugate Haemophilus influenzae type b vaccine: High efficacy and lack of herd immunity. J Pediatr 1997; 131: 869–873.

    Google Scholar 

  6. Herceg A. The decline of Haemophilus influenzae type b disease in Australia. Commun Dis Intell 1997; 21: 173–176.

    Google Scholar 

  7. Livartowski A, Boucher J, Detournay B, Reinert P. Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France. Vaccine 1996; 14: 495–500.

    Google Scholar 

  8. West DJ, Hesley TM, Jonas LC, Feeley LK, Bird SR, Burke P, et al. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Pediatr Infect Dis J 1997; 16: 593–599.

    Google Scholar 

  9. Adegbola RA, Mulholland EK, Falade AG, Secka O, Sarge-Njai R, Corrah T, et al. Haemophilus influenzae type b disease in the Western Region of The Gambia: Background surveillance for a vaccine efficacy trial. Ann Trop Paediatr 1996; 16: 103–111.

    Google Scholar 

  10. Iwarson S. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease. Vaccine 1993; 11Suppl 1: S28–S29.

    Google Scholar 

  11. Hazlewood M, Nusrat R, Kumararatne DS, Goodall M, Raykundalia C, Gong Wang D, et al. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin Exp Immunol 1993; 93: 157–164.

    Google Scholar 

  12. Salih MAM, Fredlund H, Hugosson S, Bodin L, Olcén P. Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus influezae type b in Sudanese and Swedish children. Epidemiol Infect 1993; 110: 307–316.

    Google Scholar 

  13. Scheifele DW, Meekison W, Guasparini R, Roberts A, Barreto L, Thipphawong J, et al. Evaluation of booster doses of Haemophilus influenze type b-tetanus toxoid conjugate vaccine in 18–month-old children. Vaccine 1995; 13: 104–108.

    Google Scholar 

  14. Acharya D, Bhave S, Joshi V, Bavdekar A, Pandit A. Haemophilus influenzae type b vaccine in India: Need and timing, immunogenicity and tolerance. Indian Pediatr 1997; 34: 9–15.

    Google Scholar 

  15. Kurikka S, Ölander R-M, Eskola J, Käyhty H. Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. Pediatr Infect Dis J 1996; 15: 530–535.

    Google Scholar 

  16. Zepp F, Schmitt H-J, Kaufhold A, Schuind A, Knuf M, Habermehl P, et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: Plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr 1997; 156: 18–24.

    Google Scholar 

  17. Acharya D, Desai A, Nanavaty N, Pandit A, Patel V, Shah J, et al. Evaluation of immunogenicity and tolerance of single dose Haemophilus influenzae type b-(PRP-T) vaccine. Indian Pediatr 1995; 32: 1077–1082.

    Google Scholar 

  18. Ulanova M, Hahn-Zoric M, Lau YL, Lucas A, Hanson LA. Expression of Haemophilus influenzae type b idiotype 1 on naturally acquired antibodies. Clin Exp Immunol 1996; 105: 422–428.

    Google Scholar 

  19. Levine OS, Granoff DM, Lagos R, Fritzell B, Levine MM. Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age. Vaccine 1997; 15: 325–328.

    Google Scholar 

  20. Sutton A, Vann WF, Karpas AB, Stein KE, Schneerson R. An avidin-biotin-based ELISA for quantitation of antibody to bacterial polysaccharides. J Immunol Methods 1985; 82: 215–224.

    Google Scholar 

  21. Vincent-Ballereau F, Lafleuriel MT, Marchais H, Claudel-Daniel V. Immunité naturelle vis-à-vis d' Haemophilus influenzae b. Etude par me? thode ELISA de la distribution des Ig G, Ig G1 et Ig G2 en France et en Afrique. Path Biol 1991; 39: 38–41.

    Google Scholar 

  22. Lamotte M. Initiation aux méthodes statistiques en biologie. 2nd ed. Paris (France): Masson, 1971.

    Google Scholar 

  23. Commissariat à l'Energie Atomique (France). Statistique appliquée à l'exploitation des mesures. Tome 2. Paris (France): Masson, 1978.

    Google Scholar 

  24. Gomez E, Moore A, Sanchez J, Kool J, Castellanos PL, Feris JM, et al. The epidemiology of Haemophilus influenzae type b carriage among infants and young children in Santo Domingo, Dominican Republic. Pediatr Infect Dis J 1998; 17: 782–786.

    Google Scholar 

  25. Hugosson S, Silfverdal S-A, Garpenholt Ö, Esbjörner E, Lindquist B, Vilkerfors T, et al. Invasive Haemophilus influenzae disease: Epidemiology and clinical spectrum before large-scale H. influenzae type b vaccination. Scand J Infect Dis 1995; 27: 63–67.

    Google Scholar 

  26. Rijkers GT, Sanders LAM, Zegers BJM. Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 1993; 5: 1–21.

    Google Scholar 

  27. Silfverdal SA, Bodin L, Hugosson S, Garpenholt Ö, Werner B, Esbjörner E, et al. Protective effect of breastfeeding on invasive Haemophilus influenzae infection: A case-control study in Swedish preschool children. Int J Epidemiol 1997; 26: 443–450.

    Google Scholar 

  28. Claesson BA. Epidemiology of invasive Haemophilus influenzae type b disease in Scandinavia. Vaccine 1993; 11(Suppl 1): S30–S33.

    Google Scholar 

  29. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, et al. Large-scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: Practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996; 15: 216–222.

    Google Scholar 

  30. de Benoist AC, Laurent E, Goulet V. Infections invasives à Haemophilus influenzae, Listeria monocytogenes, méningocoque, pneumocoque, streptocoques group A et groupe B en France en 1997 — Evolution 1991–1997. BEH 1999; No 15: 57–59.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de Santé Publique et de Pharmacie Clinique, Faculté de Pharmacie, Université de Nantes, Nantes, France

    Françoise Ballereau, Michelle Speich & Véronique Apaire-Marchais

  2. Centre Hospitalier de Villeneuve-Saint-Georges, Groupe d'Etudes Epidémiologiques et Prophylactiques (GEEP), France

    Françoise Ballereau

Authors
  1. Françoise Ballereau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle Speich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Véronique Apaire-Marchais
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ballereau, F., Speich, M. & Apaire-Marchais, V. Natural Haemophilus influenzae type b capsular polysaccharide antibodies in 412 infants and children from West Africa (Burkina-Faso) and France: A cross-sectional serosurvey. Eur J Epidemiol 15, 577–582 (1999). https://doi.org/10.1023/A:1007668003578

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007668003578

Search

Navigation